SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE) — FDA Approval ANDA207101 (BAXTER HLTHCARE CORP)
SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE) — FDA Approval ANDA207101 (BAXTER HLTHCARE CORP) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SUMATRIPTAN SUCCINATE; Active ingredients: SUMATRIPTAN SUCCINATE; Application number: ANDA207101.
| Brand name | SUMATRIPTAN SUCCINATE |
|---|---|
| Active ingredients | SUMATRIPTAN SUCCINATE |
| Application number | ANDA207101 |
| Sponsor | BAXTER HLTHCARE CORP |
| Dosage form | INJECTABLE |
| Route | SUBCUTANEOUS |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20230119 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →